Rayburn West Financial Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.16M Sell
8,771
-33
-0.4% -$11.3K 1.74% 20
2026
Q1
$3.1M Sell
8,804
-75
-0.8% -$26.7K 1.82% 23
2025
Q4
$2.91M Buy
+8,879
New +$2.82M 1.81% 22

Other funds holding AMGN

Rayburn West Financial Services's AMGN Position: Q2 2026 in Review

Rayburn West Financial Services reduced its Amgen (AMGN) stake by 0.37% in Q2 2026, selling an estimated $11.3K and leaving 8,771 shares worth $3.16M. The position accounts for 1.74% of the portfolio, ranked #20.

Rayburn West Financial Services first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,145 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Rayburn West Financial Services held 8,771 shares of Amgen worth $3.16M as of Q2 2026.
  • Rayburn West Financial Services sold 33 Amgen shares in Q2 2026, an estimated $11.3K.
  • Amgen made up 1.74% of Rayburn West Financial Services's portfolio in Q2 2026, its #20 holding.
  • Rayburn West Financial Services first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 3,145 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Rayburn West Financial Services's 13F filing for Q2 2026, filed 7 Aug 2026.